Monday, October 22, 2018
- 9:00AM-11:00AM
-
Abstract Number: 1584
Evaluation of the Performance of the 2016 American College of Rheumatology-European League Against Rheumatism (Acr-Eular) Classification Criteria for Primary Sjogren`S Syndrome in Different Centers of Argentina
Sjögren's Syndrome – Basic and Clinical Science Poster- 9:00AM-11:00AM
-
Abstract Number: 1383
Examining Cutaneous Disease Activity As an Outcome Measure for Clinical Trials in Dermatomyositis
Patient Outcomes, Preferences, and Attitudes Poster I: Patient-Reported Outcomes- 9:00AM-11:00AM
-
Abstract Number: 1578
Exercise Increases Aerobic Capacity in Primary Sjögren´s Syndrome: A Randomized Controlled Trial
Sjögren's Syndrome – Basic and Clinical Science Poster- 9:00AM-11:00AM
-
Abstract Number: 1204
Experience Matters in Ultrasound Assessment of Gout
Imaging of Rheumatic Diseases Poster II: Ultrasound- 9:00AM-11:00AM
-
Abstract Number: 1176
Experiences of Urban First Nations and Métis Patients Accessing and Navigating the Health System for Inflammatory Arthritis Care
Health Services Research Poster II – ACR/ARHP- 9:00AM-11:00AM
-
Abstract Number: 1717
Expert Consensus on the Screening, Treatment, and Management of Patients with Systemic Sclerosis-Interstitial Lung Disease, and the Potential Role of Anti-Fibrotics in a Treatment Paradigm for Systemic Sclerosis-Interstitial Lung Disease: A Delphi Consensus Study
Systemic Sclerosis and Related Disorders – Clinical Poster II- 9:00AM-11:00AM
-
Abstract Number: 1689
Explaining the Discrepancy between Physician and Patient-Reported Measures of Disease Activity in Systemic Lupus Erythematosus
Systemic Lupus Erythematosus – Clinical Poster II: Biomarkers and Outcomes- 9:00AM-11:00AM
-
Abstract Number: 1545
Exploring the Effects of Depressive Symptoms on the Efficacy of Sarilumab and Improvements in Health-Related Quality of Life
Rheumatoid Arthritis – Treatments Poster II: PROs, Safety and Comorbidity- 9:00AM-11:00AM
-
Abstract Number: 1586
Expression of JAK Proteins and Autophagy Markers in Sjögren’s Syndrome Patients
Sjögren's Syndrome – Basic and Clinical Science Poster- 9:00AM-11:00AM
-
Abstract Number: 1107
Expression Quantitative Trait Loci -eQTL- Analysis in Systemic Sclerosis
Systemic Sclerosis and Related Disorders – Basic Science Poster II- 9:00AM-11:00AM
-
Abstract Number: 1418
External Validation of the Autoinflammatory Disease Activity Index (AIDAI) in Patients with Colchicine-Resistant FMF, Hids/Mkd, and TRAPS: Results from a Pivotal, Phase 3 Trial of Canakinumab
Pediatric Rheumatology – Clinical Poster II: Autoinflammatory Disorders, Scleroderma, and Miscellaneous- 9:00AM-11:00AM
-
Abstract Number: 1593
Extra-Articular Manifestations, Neoplasms and Cardiovascular Events in a Series of Spondyloarthritis from a Single Center
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies- 9:00AM-11:00AM
-
Abstract Number: 1101
Extracellular Vesicle-Mediated Delivery of EBV SMALL RNA (EBER1) Activates LUPUS Nephritis Related Antiviral Immunity in Tubular Epithelial CELLS VIA TLR3
Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 1335
Extracellular Vesicles Induce Pro-Inflammatory Cytokines in Dermatomyositis